Literature DB >> 23217737

Apolipoprotein e sets the stage: response to injury triggers neuropathology.

Robert W Mahley1, Yadong Huang.   

Abstract

Apolipoprotein (apo) E4 is the major genetic risk factor for Alzheimer's disease and is associated with poor clinical outcome following traumatic brain injury and other neuropathological disorders. Protein instability and an isoform-specific apoE property called domain interaction are responsible for these neuropathological effects. ApoE4 is the most neurotoxic isoform and can induce neuropathology through various cellular pathways. Neuronal damage or stress induces apoE synthesis as part of the repair response; however, when apoE4 is expressed in neurons, its unique conformation makes it susceptible to proteolysis, resulting in the generation of neurotoxic fragments. These fragments cause pathological mitochondrial dysfunction and cytoskeletal alterations. Here, we review data supporting the hypothesis that apoE4 (> apoE3 > apoE2) has direct neurotoxic effects and highlight studies showing that blocking domain interaction reverses these detrimental effects.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23217737      PMCID: PMC4891195          DOI: 10.1016/j.neuron.2012.11.020

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  130 in total

1.  APOE genotype is a major predictor of long-term progression of disability in MS.

Authors:  J Chapman; S Vinokurov; A Achiron; D M Karussis; K Mitosek-Szewczyk; M Birnbaum; D M Michaelson; A D Korczyn
Journal:  Neurology       Date:  2001-02-13       Impact factor: 9.910

Review 2.  An inherited variable poly-T repeat genotype in TOMM40 in Alzheimer disease.

Authors:  Allen D Roses
Journal:  Arch Neurol       Date:  2010-05

3.  Apolipoprotein E4 domain interaction occurs in living neuronal cells as determined by fluorescence resonance energy transfer.

Authors:  Qin Xu; Walter J Brecht; Karl H Weisgraber; Robert W Mahley; Yadong Huang
Journal:  J Biol Chem       Date:  2004-03-30       Impact factor: 5.157

Review 4.  The cell biology and physiologic relevance of ApoE recycling.

Authors:  S Fazio; M F Linton; L L Swift
Journal:  Trends Cardiovasc Med       Date:  2000-01       Impact factor: 6.677

Review 5.  Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease.

Authors:  Robert W Mahley; Karl H Weisgraber; Yadong Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

6.  Apolipoprotein E-containing lipoproteins protect neurons from apoptosis via a signaling pathway involving low-density lipoprotein receptor-related protein-1.

Authors:  Hideki Hayashi; Robert B Campenot; Dennis E Vance; Jean E Vance
Journal:  J Neurosci       Date:  2007-02-21       Impact factor: 6.167

7.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Authors:  W J Strittmatter; A M Saunders; D Schmechel; M Pericak-Vance; J Enghild; G S Salvesen; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

8.  Oxidative stress increases expression and activity of BACE in NT2 neurons.

Authors:  Elena Tamagno; Paola Bardini; Alessandra Obbili; Antonella Vitali; Roberta Borghi; Damiano Zaccheo; Maria A Pronzato; Oliviero Danni; Mark A Smith; George Perry; Massimo Tabaton
Journal:  Neurobiol Dis       Date:  2002-08       Impact factor: 5.996

9.  Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia.

Authors:  Federica Agosta; Keith A Vossel; Bruce L Miller; Raffaella Migliaccio; Stephen J Bonasera; Massimo Filippi; Adam L Boxer; Anna Karydas; Katherine L Possin; Maria Luisa Gorno-Tempini
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-22       Impact factor: 11.205

10.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

View more
  136 in total

1.  Human-specific derived alleles of CD33 and other genes protect against postreproductive cognitive decline.

Authors:  Flavio Schwarz; Stevan A Springer; Tasha K Altheide; Nissi M Varki; Pascal Gagneux; Ajit Varki
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-30       Impact factor: 11.205

Review 2.  The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives.

Authors:  Russell H Swerdlow; Jeffrey M Burns; Shaharyar M Khan
Journal:  Biochim Biophys Acta       Date:  2013-09-23

3.  Longitudinal clinical, neuropsychological, and neuroimaging characterization of a kindred with a 12-octapeptide repeat insertion in PRNP: the next generation.

Authors:  Ryan A Townley; Angelina J Polsinelli; Julie A Fields; Mary M Machulda; David T Jones; Jonathan Graff-Radford; Kejal M Kantarci; Val J Lowe; Rosa V Rademakers; Matt C Baker; Neeraj Kumar; Bradley F Boeve
Journal:  Neurocase       Date:  2020-06-30       Impact factor: 0.881

4.  Associations of Apolipoprotein E ε4 Genotype and Ball Heading With Verbal Memory in Amateur Soccer Players.

Authors:  Liane E Hunter; Yun Freudenberg-Hua; Peter Davies; Mimi Kim; Richard B Lipton; Walter F Stewart; Priyanka Srinivasan; ShanShan Hu; Michael L Lipton
Journal:  JAMA Neurol       Date:  2020-04-01       Impact factor: 18.302

5.  A Drosophila model of closed head traumatic brain injury.

Authors:  Rebeccah J Katzenberger; Carin A Loewen; Douglas R Wassarman; Andrew J Petersen; Barry Ganetzky; David A Wassarman
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-14       Impact factor: 11.205

6.  Binding of apolipoprotein E inhibits the oligomer growth of amyloid-β peptide in solution as determined by fluorescence cross-correlation spectroscopy.

Authors:  Sonny Ly; Robin Altman; Jitka Petrlova; Yu Lin; Silvia Hilt; Thomas Huser; Ted A Laurence; John C Voss
Journal:  J Biol Chem       Date:  2013-02-21       Impact factor: 5.157

Review 7.  Advancing Biological Understanding and Therapeutics Discovery with Small-Molecule Probes.

Authors:  Stuart L Schreiber; Joanne D Kotz; Min Li; Jeffrey Aubé; Christopher P Austin; John C Reed; Hugh Rosen; E Lucile White; Larry A Sklar; Craig W Lindsley; Benjamin R Alexander; Joshua A Bittker; Paul A Clemons; Andrea de Souza; Michael A Foley; Michelle Palmer; Alykhan F Shamji; Mathias J Wawer; Owen McManus; Meng Wu; Beiyan Zou; Haibo Yu; Jennifer E Golden; Frank J Schoenen; Anton Simeonov; Ajit Jadhav; Michael R Jackson; Anthony B Pinkerton; Thomas D Y Chung; Patrick R Griffin; Benjamin F Cravatt; Peter S Hodder; William R Roush; Edward Roberts; Dong-Hoon Chung; Colleen B Jonsson; James W Noah; William E Severson; Subramaniam Ananthan; Bruce Edwards; Tudor I Oprea; P Jeffrey Conn; Corey R Hopkins; Michael R Wood; Shaun R Stauffer; Kyle A Emmitte
Journal:  Cell       Date:  2015-06-04       Impact factor: 41.582

Review 8.  Genetic underpinnings of cerebral edema in acute brain injury: an opportunity for pathway discovery.

Authors:  Elayna Kirsch; Natalia Szejko; Guido J Falcone
Journal:  Neurosci Lett       Date:  2020-05-26       Impact factor: 3.046

Review 9.  Understanding the impact of sex and gender in Alzheimer's disease: A call to action.

Authors:  Rebecca A Nebel; Neelum T Aggarwal; Lisa L Barnes; Aimee Gallagher; Jill M Goldstein; Kejal Kantarci; Monica P Mallampalli; Elizabeth C Mormino; Laura Scott; Wai Haung Yu; Pauline M Maki; Michelle M Mielke
Journal:  Alzheimers Dement       Date:  2018-06-12       Impact factor: 21.566

10.  Combined effects of Alzheimer risk variants in the CLU and ApoE genes on ventricular expansion patterns in the elderly.

Authors:  Florence F Roussotte; Boris A Gutman; Sarah K Madsen; John B Colby; Paul M Thompson
Journal:  J Neurosci       Date:  2014-05-07       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.